Abstract:Abstract PROTACs are molecules that combine a target-binding warhead with an E3 ligase-recruiting moiety; by drawing the target protein into a ternary complex with the E3 ligase, PROTACs induce target protein degradation. While PROTACs hold exciting potential as chemical probes and as therapeutic agents, development of a PROTAC typically requires synthesis of numerous analogs to thoroughly explore variations on the chemical linker; without extensive trial and error, it is unclear how to link the two protein-recruiting moieties to promote formation of a productive ternary complex. Here, we describe a structure-based computational method for evaluating suitability of a given linker for ternary complex formation. Our method uses Rosetta to dock the protein components, then builds the PROTAC from its component fragments into each binding mode; complete models of the ternary complex are then refined. We apply this approach to retrospectively evaluate multiple PROTACs from the literature, spanning diverse target proteins. We find that modeling ternary complex formation is sufficient to explain both activity and selectivity reported for these PROTACs, implying that other cellular factors are not key determinants of activity in these cases. We further find that interpreting PROTAC activity is best approached using an ensemble of structures of the ternary complex rather than a single static conformation, and that members of a structurally-conserved protein family can be recruited by the same PROTAC through vastly different binding modes. To encourage adoption of these methods and promote further analyses, we disseminate both the computational methods and the models of ternary complexes. Significance Statement Recent years have brought a flood of interest in developing compounds that selectively degrade protein targets in cells, as exemplified by PROTACs. Fully realizing the promise of PROTACs to transform chemical biology by delivering degraders of diverse and undruggable protein targets has been impeded, however, by the fact that designing a suitable chemical linker between the functional moieties requires extensive trial and error. Here, we describe a structure-based computational method to predict PROTAC activity. We envision that this approach will allow design and optimization of PROTACs for efficient target degradation, selection of E3 ligases best suited for pairing with a given target protein, and understanding the basis by which PROTACs can exhibit different target selectivity than their component warheads.

Cystic meningiomas in 2 dogs.

Development of PROTACs Using Computational Approaches

PROTACs: an Emerging Targeting Technique for Protein Degradation in Drug Discovery

In Silico Tools in PROTACs design

PROTAC-Design-Evaluator (PRODE): An Advanced Method for In-Silico PROTAC Design

Load management by voltage optimization: Experimental investigation of voltage variation effect on lighting loads

PROTACable Is an Integrative Computational Pipeline of 3-D Modeling and Deep Learning To Automate the De Novo Design of PROTACs

An overview of PROTACs: a promising drug discovery paradigm

Importance of Three-Body Problems and Protein-Protein Interactions in Proteolysis-Targeting Chimera Modeling: Insights from Molecular Dynamics Simulations

Chemistries of bifunctional PROTAC degraders

Proteolysis-targeting chimaeras (PROTACs) as pharmacological tools and therapeutic agents: advances and future challenges

Novel Design Strategies to Enhance the Efficiency of Proteolysis Targeting Chimeras

Proteolysis-targeting chimeras in biotherapeutics: Current trends and future applications

Benchmarking Methods for PROTAC Ternary Complex Structure Prediction

Restraining the power of Proteolysis Targeting Chimeras in the cage: A necessary and important refinement for therapeutic safety

Analysis and Retrieval Techniques for Motion and Music Data

Rationalizing PROTAC-mediated ternary complex formation using Rosetta

Proteolysis-targeting chimeras (PROTACs) in cancer therapy

A close-up shot of protein-protein docking, from experiment to theory and reverse with the PROTAC performers

[Microbiological transformation of pyridine compounds].

Integrative Modeling of PROTAC-Mediated Ternary Complexes